NE LB 1043
deadInclude prescription antidepressants, antipsychotics, and anticonvulsants on the preferred drug list under the Medical Assistance Act
Nebraska · 2026 Regular Session (109th Legislature, 2nd Session) · legislature
Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.
Quick answers
Did NE LB 1043 pass?
No. NE LB 1043 did not pass — it was defeated or died in the legislative process. Latest recorded action (2026-04-17): Indefinitely postponed
What is NE LB 1043 about?
NE LB 1043 is a bill in the 2026 Regular Session (109th Legislature, 2nd Session) titled “Include prescription antidepressants, antipsychotics, and anticonvulsants on the preferred drug list under the Medical Assistance Act”.
Who sponsors NE LB 1043?
Meyer, G. is the primary sponsor of NE LB 1043.
- Introduced
- 2026-01-14
- Latest action
- 2026-04-17 — Indefinitely postponed
- Bill type
- bill
- Last updated
- —
Sponsors
- Meyer, G.primary
Committees
Not provided by source.
Action timeline
Newest first
2026-04-17
Indefinitely postponed
committee-failure
2026-01-27
Notice of hearing for February 05, 2026
2026-01-16
Referred to Health and Human Services Committee
referral-committee
2026-01-15
Kauth FA702 filed
filing
2026-01-14
Date of introduction
introduction
Versions
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:27:15.448898Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NE&identifier=LB 1043. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.